肝硬化合并脓毒症休克患者的微血管舒张反应增强
这项前瞻性观察研究纳入30例脓毒症休克成人患者(肝硬化10例、无肝硬化20例),在初始复苏后测量皮肤微血管对局部乙酰胆碱离子电渗的反应性。肝硬化患者Child-Pugh C级占80%且均有腹水,SOFA评分更高(11.5 vs 6.5,p<0.01),ICU死亡率更高(70% vs 15%,p<0.01),动脉乳酸为无肝硬化组的三倍(6.0 vs 2.0 mmol/L,p<0.01)。基线皮肤微血管血流两组无统计学差异(p=0.29),但乙酰胆碱刺激后肝硬化组血流增加644% vs 169%(p=0.03),曲线下面积16,412 vs 2,664灌注单位(p<0.001)。作者认为这种过度舒张反应可能解释升压药抵抗,并为针对一氧化氮通路的治疗试验提供依据。
要点
- 肝硬化合并脓毒症休克患者ICU死亡率70% vs 无肝硬化患者15%(p<0.01),SOFA评分11.5 vs 6.5(p<0.01)。
- 肝硬化组动脉乳酸6.0 mmol/L vs 无肝硬化组2.0 mmol/L(p<0.01),约为后者的三倍。
- 乙酰胆碱刺激后皮肤微血管血流增加肝硬化组644% vs 无肝硬化组169%(p=0.03)。
- 微血管反应性曲线下面积肝硬化组16,412灌注单位 vs 无肝硬化组2,664灌注单位(p<0.001),约七倍。
- 基线皮肤微血管血流两组无统计学差异(4.94 vs 6.95灌注单位,p=0.29),外周组织灌注和整体血流动力学参数两组无差异。
适用人群与场景
- 因脓毒症休克收入三级教学医院内科ICU的成人患者,包括肝硬化与无肝硬化者。
- 肝硬化患者中Child-Pugh C级占80%,全部有腹水。
研究设计与关键结果
- 前瞻性观察研究,纳入30例脓毒症休克成人患者(60%男性),肝硬化10例、无肝硬化20例,中位年龄61岁(54-74岁)。
- 初始复苏后记录整体血流动力学参数,并测量皮肤微血管对局部乙酰胆碱离子电渗的反应性。
- 肝硬化组SOFA评分11.5(9.0-14.0)vs 无肝硬化组6.5(5.0-8.3),p<0.01;ICU死亡率70% vs 15%,p<0.01。
- 肝硬化组动脉乳酸6.0 mmol/L(3.9-8.0 mmol/L)vs 无肝硬化组2.0 mmol/L(0.9-3.5 mmol/L),p<0.01。
- 基线皮肤微血管血流肝硬化组4.94灌注单位(3.45-8.73)vs 无肝硬化组6.95灌注单位(5.24-8.38),p=0.29,无统计学差异。
- 乙酰胆碱刺激后皮肤微血管血流增加肝硬化组644%(217-966%)vs 无肝硬化组169%(73-505%),p=0.03。
- 微血管反应性曲线下面积肝硬化组16,412灌注单位(13,898-19,041)vs 无肝硬化组2,664灌注单位(969-4,604),p<0.001。
- 外周组织灌注和整体血流动力学参数两组无差异。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,肝硬化合并脓毒症休克患者存在过度微血管舒张反应,该结果可能解释升压药抵抗,并为未来针对一氧化氮通路的治疗试验提供依据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Cirrhosis is associated with hemodynamic and vascular disorders. However, microvascular reactivity of cirrhotic patients in the context of sepsis has poorly been investigated.
DESIGN: Prospective observational study.
SETTING: Medical ICU in a tertiary teaching hospital.
PATIENTS: We prospectively included adult patients admitted in the ICU for septic shock with and without cirrhosis. After initial resuscitation, global hemodynamic parameters were recorded and skin microvascular reactivity to local acetylcholine iontophoresis was measured.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Thirty patients with septic shock were included (60% male), 10 with cirrhosis and 20 without, with a median age of 61 years (54-74 yr). Cirrhotic patients were mainly classed as Child-Pugh C (80%) and all of them had ascites. Sequential Organ Failure Assessment score and ICU mortality of cirrhotic patients were higher than the noncirrhotic patients, respectively (6.5 [5.0-8.3] vs 11.5 [9.0-14.0]; p < 0.01; 15% vs 70%; p < 0.01). Peripheral tissue perfusion and global hemodynamic parameters were not different between the cirrhotic and noncirrhotic patients but arterial lactate level was three times higher in patients with cirrhosis (6.0 mmol/L [3.9-8.0 mmol/L] vs 2.0 mmol/L [0.9-3.5 mmol/L]; p < 0.01). Basal skin microvascular blood flow was not statistically different between the groups (4.94 perfusion units [3.45-8.73 perfusion units] vs 6.95 perfusion units [5.24-8.38 perfusion units]; p = 0.29). After acetylcholine simulation, skin microvascular blood flow increased more in cirrhotic patients than in noncirrhotic patients (644% [217-966%] vs 169% [73-505%], p = 0.03). Global microvascular reactivity was seven times higher in cirrhotic patients (area under the curve, 16,412 perfusion units [13,898-19,041 perfusion units] vs 2,664 perfusion units [969-4,604 perfusion units]; p < 0.001).
CONCLUSIONS: We identified an exaggerated vasodilating microvascular response in cirrhotic patients with septic shock. Such a result may explain vasopressor resistance and paves the way for future therapeutic trials, targeting nitric oxide pathway specifically in this population.
参考来源
- Hariri G, Urbina T, Lavillegrand JR, et al. Exaggerated Microvascular Vasodilating Responses in Cirrhotic Patients With Septic Shock. Crit Care Med. 2021. PMID: 33591010. doi:10.1097/CCM.0000000000004846
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。